WINDTREE THERAPEUTICS INC /DE/ Restructuring and Related Cost, Number of Positions Eliminated
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Restructuring and Related Cost, Number of Positions Eliminated of 2000.00% as of 2017-07-13, per its 10-K filed 2018-04-17.
Discontinued › Notes › Restructuring and Related Activities › Restructuring and Related Cost, Positions Eliminated
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2018-04-17
- 2017-07-13: Restructuring and Related Cost, Number of Positions Eliminated 2000.00%.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated |
|---|---|
| 2017-07-13 | 2000.00% 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |